Mechanism |
Reference |
Type of study |
Reduces myocardial metabolic demand and oxygen consumption |
Miki et al. 1998 55, Schwartz et al. 2001 56, Dae et al. 2003 57, Maeng et al. 2003 58 |
Animal model |
Preserves myocyte membrane function, intracellular calcium and pH hemostasis |
Schwartz et al. 2001 56, Inoue et al 2003 28 |
Animal model |
Decreases free radical and cytotoxin generation |
Maeng et al. 2006 59 |
Animal model |
Decreases infarct size |
Otake et al. 2007 60 |
Animal model |
Prevents microvascular obstruction and no-reflow phenomenon |
Hale et al. 2003 61, Gotberg et al. 2008 62 |
Animal model |
Inhibits mediators of inflammatory response and myocyte apoptosis |
Dixon et al. 2005 50 |
Human |
Reduces post-infarct reactive hyperemia |
Olivecrona et al. 2007 29 |
Animal model |
Maintains myocardial cell integrity and mitchondrial function |
Ning et al. 1998 63, 2007 64 |
Animal model |
Inhibits platelet aggregation |
Frelinger et al. 2003 65 |
Human |